Indanyl carbenicillin in urinary tract infections.  A report of early clinical experience in Spain.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001437:Bacteriuria / Q000188:drug therapy; D002228:Carbenicillin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011511:Proteus / Q000302:isolation & purification; D011549:Pseudomonas / Q000302:isolation & purification; D013030:Spain; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy*
D007189:Indans; D002228:Carbenicillin